Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography - PubMed (original) (raw)
Clinical Trial
. 1998 Jul 2;339(1):5-11.
doi: 10.1056/NEJM199807023390102.
V C McKie, L Hsu, B Files, E Vichinsky, C Pegelow, M Abboud, D Gallagher, A Kutlar, F T Nichols, D R Bonds, D Brambilla
Affiliations
- PMID: 9647873
- DOI: 10.1056/NEJM199807023390102
Free article
Clinical Trial
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
R J Adams et al. N Engl J Med. 1998.
Free article
Abstract
Background: Blood transfusions prevent recurrent stroke in children with sickle cell anemia, but the value of transfusions in preventing a first stroke is unknown. We used transcranial Doppler ultrasonography to identify children with sickle cell anemia who were at high risk for stroke and then randomly assigned them to receive standard care or transfusions to prevent a first stroke.
Methods: To enter the study, children with sickle cell anemia and no history of stroke had to have undergone two transcranial Doppler studies that showed that the time-averaged mean blood-flow velocity in the internal carotid or middle cerebral artery was 200 cm per second or higher. The patients were randomly assigned to receive standard care or transfusions to reduce the hemoglobin S concentration to less than 30 percent of the total hemoglobin concentration. The incidence of stroke (cerebral infarction or intracranial hemorrhage) was compared between the two groups.
Results: A total of 130 children (mean [+/-SD] age, 8.3+/-3.3 years) were enrolled; 63 were randomly assigned to receive transfusions and 67 to receive standard care. At base line, the transfusion group had a slightly lower mean hemoglobin concentration (7.2 vs. 7.6 g per deciliter, P=0.001) and hematocrit (20.4 vs. 21.7 percent, P=0.002). Ten patients dropped out of the transfusion group, and two patients crossed over from the standard-care group to the transfusion group. There were 10 cerebral infarctions and 1 intracerebral hematoma in the standard-care group, as compared with 1 infarction in the transfusion group -- a 92 percent difference in the risk of stroke (P<0.001). This result led to the early termination of the trial.
Conclusions: Transfusion greatly reduces the risk of a first stroke in children with sickle cell anemia who have abnormal results on transcranial Doppler ultrasonography.
Comment in
- Prevention of stroke by transfusions in children with sickle cell anemia.
Sarnaik SA. Sarnaik SA. N Engl J Med. 1998 Nov 12;339(20):1477-8. N Engl J Med. 1998. PMID: 9841322 No abstract available. - A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.
Lewen MO, Kavanagh PL, Sobota AE. Lewen MO, et al. Am J Hematol. 2017 Jun;92(6):E121-E122. doi: 10.1002/ajh.24727. Epub 2017 Apr 29. Am J Hematol. 2017. PMID: 28335074 No abstract available.
Similar articles
- Stroke prevention trial in sickle cell anemia.
Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA, et al. Adams RJ, et al. Control Clin Trials. 1998 Feb;19(1):110-29. doi: 10.1016/s0197-2456(97)00099-8. Control Clin Trials. 1998. PMID: 9492971 Clinical Trial. - The use of transcranial ultrasonography to predict stroke in sickle cell disease.
Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. Adams R, et al. N Engl J Med. 1992 Feb 27;326(9):605-10. doi: 10.1056/NEJM199202273260905. N Engl J Med. 1992. PMID: 1734251 - Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NLC, Cohen AR, Pressel S, Adams RJ. Ware RE, et al. Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6. Lancet. 2016. PMID: 26670617 Free PMC article. Clinical Trial. - Big strokes in small persons.
Adams RJ. Adams RJ. Arch Neurol. 2007 Nov;64(11):1567-74. doi: 10.1001/archneur.64.11.1567. Arch Neurol. 2007. PMID: 17998439 Review. - Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study.
Adams RJ. Adams RJ. J Child Neurol. 2000 May;15(5):344-9. doi: 10.1177/088307380001500511. J Child Neurol. 2000. PMID: 10830201 Review.
Cited by
- Beyond Ischemia: The Rare Occurrence of Hemorrhagic Strokes in Pediatric Sickle Cell Anemia.
Mustafa M, Amawi M, Altoonisi MM, Soliman W, Kamal M, Asaad Z, Albalawi A, Alharbi J, Awadalla AM, A-Azim Ahmed M, Hanafy E. Mustafa M, et al. Cureus. 2024 Oct 5;16(10):e70871. doi: 10.7759/cureus.70871. eCollection 2024 Oct. Cureus. 2024. PMID: 39497863 Free PMC article. - Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations.
Bhatia M, Sheth S. Bhatia M, et al. J Blood Med. 2015 Jul 10;6:229-38. doi: 10.2147/JBM.S60515. eCollection 2015. J Blood Med. 2015. PMID: 26203293 Free PMC article. Review. - Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease.
Kelly S. Kelly S. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):646-652. doi: 10.1182/hematology.2023000498. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066846 Free PMC article. - Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE; Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH). Alvarez O, et al. Am J Hematol. 2013 Nov;88(11):932-8. doi: 10.1002/ajh.23547. Epub 2013 Aug 30. Am J Hematol. 2013. PMID: 23861242 Free PMC article. Clinical Trial. - Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke.
Hakami F, Alhazmi E, Busayli WM, Althurwi S, Darraj AM, Alamir MA, Hakami A, Othman RA, Moafa AI, Mahasi HA, Madkhali MA. Hakami F, et al. Cureus. 2023 Dec 15;15(12):e50577. doi: 10.7759/cureus.50577. eCollection 2023 Dec. Cureus. 2023. PMID: 38107212 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical